-
Product Insights
NewElectrophysiology Ablation Catheters Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Electrophysiology Ablation Catheters Pipeline Market Report Overview Electrophysiology ablation is applicable for a wide variety of arrhythmias and has an extremely high success rate with low rates of complication and recurrence. The electrophysiology ablation catheters pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and...
-
Product Insights
NewVentilators Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Ventilators Pipeline Market Report Overview A ventilator is an artificial respiratory support device. It uses air pressure to deliver air into the lungs and alternatively, creates vacuum pressure to release carbon dioxide from it. The ventilators pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials,...
-
Product Insights
NewLikelihood of Approval Analysis for Acute Coronary Syndrome
Overview How likely is it that the drugs in Acute Coronary Syndrome will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Acute Coronary Syndrome Overview Acute coronary syndrome (ACS) encompasses ST-elevation myocardial...
-
Thematic Analysis
NewWealth Management Sector Scorecard – Thematic Intelligence
Wealth Management Sector Scorecard Thematic Intelligence Report Overview The wealth management sector must continuously invest in key themes to capture more market share. Digital investment platforms with the infusion of emerging technologies, such as artificial intelligence (AI) and machine learning, can offer customers efficient personalized services. This will not only help players retain customers but also gain a competitive advantage. Environmental, social, and governance (ESG) services remain a key theme in the wealth space, accelerated due to the pandemic. Wealth...
-
Sector Analysis
NewOil and Gas Final Investment Decisions (FIDs) in 2024, H1 Edition
Oil and Gas FIDs Market Report Overview The oil & gas FIDs market report H1 2024 edition provides valuable insights into the major projects targeted for FIDs in 2024 across the oil and gas value chain. Key Upstream Projects Targeting FIDs in 2024 Whiptail, Bonga North, Zama, South Lokichar Development (Phase 1), and Sea Lion Key Midstream Projects Targeting FIDs in 2024 Coral Norte Floating, Akwa Ibom Floating, Papua, Sonora Phase I Train III, Cedar Floating, and Brownsville Key Downstream...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ST316 in Metastatic Breast Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ST316 in Metastatic Breast Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ST316 in Metastatic Breast Cancer Drug Details: ST-316 is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ST316 in Metastatic Melanoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ST316 in Metastatic Melanoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ST316 in Metastatic Melanoma Drug Details: ST-316 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ST316 in Non-Small Cell Lung Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ST316 in Non-Small Cell Lung Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ST316 in Non-Small Cell Lung Cancer Drug Details: ST-316 is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ST316 in Metastatic Colorectal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ST316 in Metastatic Colorectal Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ST316 in Metastatic Colorectal Cancer Drug Details: ST-316 is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ST316 in Metastatic Ovarian Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ST316 in Metastatic Ovarian Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ST316 in Metastatic Ovarian Cancer Drug Details: ST-316 is under development...